These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16565599)

  • 21. Case Report: Successful Treatment of Refractory Interstitial Lung Disease With Cyclosporine A and Pirfenidone in a Child With SLE.
    Deng L; Chen Y; Hu X; Zhou J; Zhang Y
    Front Immunol; 2021; 12():708463. PubMed ID: 34671344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pneumatosis cystoides intestinalis associated with intravenous pulse cyclophosphamide treatment for systemic lupus erythematosus].
    Nonaka D; Higuchi M; Yoshizawa S; Horiuchi T; Nakashima H; Niho Y
    Ryumachi; 1998 Aug; 38(4):605-10. PubMed ID: 9785989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
    Yamaji K; Kim YJ; Tsuda H; Takasaki Y
    Ther Apher Dial; 2008 Aug; 12(4):298-305. PubMed ID: 18789117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
    Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
    Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A patient with systemic lupus erythematosus who developed massive small intestinal hemorrhaging during treatment for chronic lupus peritonitis.
    Kawashiri SY; Nishino A; Sueyoshi E; Okada A; Koga T; Yamasaki S; Nakamura H; Origuchi T; Kawakami A
    Mod Rheumatol; 2012 Apr; 22(2):312-5. PubMed ID: 21761227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
    Ogawa H; Kameda H; Amano K; Takeuchi T
    Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.
    Austin HA; Illei GG; Braun MJ; Balow JE
    J Am Soc Nephrol; 2009 Apr; 20(4):901-11. PubMed ID: 19297556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.
    Dostál C; Tesar V; Rychlík I; Zabka J; Vencovský J; Bartûnková J; Stejskalová A; Tegzova D
    Lupus; 1998; 7(1):29-36. PubMed ID: 9493146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A successful case of lupus myelitis treated with intravenous pulse methylprednisolone and pulse cyclophosphamide therapy.
    Sonoda-Shimada K; Kajihara I; Jinnin M; Ihn H
    Drug Discov Ther; 2020 Sep; 14(4):209-210. PubMed ID: 32863325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Refractory hemophagocytic syndrome in systemic lupus erythematosus successfully treated with intermittent intravenous cyclophosphamide: three case reports and literature review.
    Ueda Y; Yamashita H; Takahashi Y; Kaneko H; Kano T; Mimori A
    Clin Rheumatol; 2014 Feb; 33(2):281-6. PubMed ID: 24343456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intermittent intravenous pulse cyclophosphamide treatment in systemic lupus erythematosus.
    Malaviya AN; Singh RR; Sindhwani R; Singh YN; Ahujà RK; Bhuyan UN; Khare SD; Kumar A; Malaviya R; Negi PC
    Indian J Med Res; 1992 Apr; 96():101-8. PubMed ID: 1428048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
    Hu J; Li CW; Zhang X; Pi SH; Zhao JS; Chen XY; Liu Y
    Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):430-4. PubMed ID: 14748998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous cyclophosphamide--resistant systemic lupus erythematosus in Arizona.
    Dixit MP; Bracamonte E; Dixit N
    Pediatr Nephrol; 2004 Jul; 19(7):738-43. PubMed ID: 15141346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis.
    El-Sehemy MS; Al-Saaran AM; Baddour NM; Adam AG; Moez PE
    Egypt J Immunol; 2006; 13(1):39-52. PubMed ID: 17974149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of systemic lupus erythematosus (SLE) with a neurogenic bladder, successful treatment with intravenous cyclophosphamide pulse therapy].
    Nakagawa M; Nishinarita M
    Ryumachi; 1999 Oct; 39(5):763-7. PubMed ID: 10614171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
    Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
    Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.
    Huong DL; Amoura Z; Duhaut P; Sbai A; Costedoat N; Wechsler B; Piette JC
    J Rheumatol; 2002 Dec; 29(12):2571-6. PubMed ID: 12465154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.
    Koga T; Umeda M; Endo Y; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Murakami N; Kitajima M; Kawakami A
    Int J Rheum Dis; 2018 Jun; 21(6):1287-1292. PubMed ID: 29879312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H; Tsugawa K; Tsuruga K; Suzuki K; Nakahata T; Ito E; Waga S
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.